Listed by the USPTO as CRAIGO, WILLIAM A
Tech Center 1600 • Art Units: 1615 1621 1625
This examiner grants 49% of resolved cases
CRAIGO, WILLIAM A works in USPTO Technology Center 1600 and art unit 1615. He has 750 resolved cases, with a 48.9% allowance rate and a 38.1% interview lift. The median time to allowance is 1281 days. The combination of a lower allowance rate and strong interview association makes interview preparation and focused amendment practice important considerations for applicants.
The principal companies are Freudenberg Medical Hemoteq GmbH, Boston Scientific Corporation, and R.P. Scherer Technologies LLC. The leading firms are pH IP Law, Knobbe, Martens, Olson & Bear, LLP, and Arnold & Porter Kaye Scholer LLP - Roquette Freres. These participants provide context for the examiner’s medical technology docket.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18796716 | HEMOSTATIC COMPOSITIONS AND RELATED METHODS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18709316 | GRANULE COMPRISING ENCAPSULATED ACTIVE INGREDIENTS | Non-Final OA | DSM IP ASSETS B.V. |
| 18575474 | SOFTGEL CAPSULE | Final Rejection | R.P. Scherer Technologies, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy48.9% of resolved applications examined by William A Craigo were allowed (750 resolved cases), compared with 43.4% across Art Unit 1615 over the last five years.
This examiner's interview lift is +38.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by William A Craigo took 1,281 days on average from filing to allowance.
William A Craigo examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
